Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Alcohol Dependence
NCT00877734Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in alcohol dependence comparing Baclofen with Placebo (2 arms). Primary endpoint: Percentage of heavy drinking days at 2 years. Started Apr 2005; status: completed.
02
Drugs
baclofen
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00877734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877734.